Page last updated: 2024-10-27

gentamicin and Febrile Neutropenia

gentamicin has been researched along with Febrile Neutropenia in 2 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Febrile Neutropenia: Fever accompanied by a significant reduction in the number of NEUTROPHILS.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the impact of an antimicrobial stewardship (AMS) intervention, involving introduction of new guidelines on the treatment of febrile neutropenia (FN), on improving the use of gentamicin in paediatric oncology patients."9.27Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia. ( Bialkowski, S; Clark, J; Consuelo Llanos Paez, C; Hennig, S; Lawson, R; Natanek, D; Staatz, CE, 2018)
"The pharmacokinetics of gentamicin in pediatric patients with febrile neutropenia is described, and the adequacy of initial dosing of once-daily gentamicin assessed at Queensland's largest Children's Hospital."7.83Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia. ( Bialkowski, S; Clark, J; Hennig, S; Lawson, R; Staatz, CE, 2016)
"To evaluate the impact of an antimicrobial stewardship (AMS) intervention, involving introduction of new guidelines on the treatment of febrile neutropenia (FN), on improving the use of gentamicin in paediatric oncology patients."5.27Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia. ( Bialkowski, S; Clark, J; Consuelo Llanos Paez, C; Hennig, S; Lawson, R; Natanek, D; Staatz, CE, 2018)
"The pharmacokinetics of gentamicin in pediatric patients with febrile neutropenia is described, and the adequacy of initial dosing of once-daily gentamicin assessed at Queensland's largest Children's Hospital."3.83Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia. ( Bialkowski, S; Clark, J; Hennig, S; Lawson, R; Staatz, CE, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hennig, S2
Staatz, CE2
Natanek, D1
Bialkowski, S2
Consuelo Llanos Paez, C1
Lawson, R2
Clark, J2

Trials

1 trial available for gentamicin and Febrile Neutropenia

ArticleYear
Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:2

    Topics: Child; Child, Preschool; Febrile Neutropenia; Female; Gentamicins; Gram-Negative Bacteria; Gram-Nega

2018

Other Studies

1 other study available for gentamicin and Febrile Neutropenia

ArticleYear
Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia.
    Therapeutic drug monitoring, 2016, Volume: 38, Issue:6

    Topics: Anti-Bacterial Agents; Area Under Curve; Child; Child, Preschool; Drug Administration Schedule; Febr

2016